News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

AcronGenomics Inc. (AGNM)’s Business Associate Molecular Vision Ltd. Appoints Peter Woodford as Chairman



2/24/2009 8:44:01 AM

LONDON--(BUSINESS WIRE)--Acrongenomics, Inc. (OTCBB:AGNM) is pleased to announce today that its business associate Molecular Vision Limited, an Imperial College London spin-out company developing quantitative point-of-care (POC) diagnostic devices, has appointed Peter Woodford as Non-Executive Chairman. The appointment serves to strengthen the board as Molecular Vision prepares to commercialise its novel detection technology, focusing on low cost POC diagnostic tests in a miniaturised, easy-to-use, disposable format.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES